Statins for low CVD risk? Check glucose first
July 23, 2013|Type 2 Diabetes ICYMI
Author and Disclosure Information
Major finding: In patients with a 5-year CVD risk of 5% and normal glucose tolerance, statins were not cost effective ($101,800 per quality-adjusted life-year).
Data source: The study population included a combined sample of nondiabetic participants in five large-scale trials: ASCOT-LLA, JUPITER, WOSCOPS, MEGA, and AFCAPS/TexCAPS.
Disclosures: Dr. Zhang and Dr. Zhou reported having no relevant financial disclosures.
AT ADA 2013
Dr. Zhou and Dr. Zhang said they had no relevant financial disclosures.
To earn 0.25 hours AMA PRA Category 1 credit after reading this article, take the post-test here.
On Twitter @NaseemSMiller
